However, recently, the use of Glucagon-Like Peptide-1 receptor agonists (GLP-1RAs) has gained significant attention for their effectiveness in weight-loss and diabetes management and are increasingly being used as an alternative to invasive surgeries (4). The gene discussed is GLP1R; the disease is diabetes mellitus.